Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ren Fail ; 37(3): 439-45, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25598237

RESUMO

BACKGROUND: Neutrophil gelatinase-associated lipocalin (NGAL) is postulated to be a highly sensitive and specific marker of acute kidney injury (AKI). The aim of this study was to assess the factors affecting serum and urine total NGAL in preterm newborns, limiting the role of this new potential marker of AKI. METHODS: Serum and urinary total NGAL concentrations were determined in 57 preterm infants admitted to the Neonatal Intensive Care Unit in the following points of time: first week of life, between 8 and 14 days of life, and after the fourth week of life. Patients' clinical conditions were evaluated based on NTISS (Neonatal Therapeutic Intervention Scoring System). Two gestational age subgroups were distinguished: ≤29 and 30 to 35 weeks of gestation. We sought correlation between total NGAL values and gestational age, birth weight, Apgar score and severity of clinical condition, with particular interest in inflammatory status. RESULTS: Serum and urinary total NGAL concentration correlated with inflammatory markers, such as CRP and procalcitonin, as well as with NTISS values. Birth weight and gestational age influence urinary NGAL (uNGAL) values in the first two weeks of life. In AKI (N = 8) patients uNGAL values were significantly higher than in non-AKI newborns. CONCLUSIONS: We conclude that inflammatory status and prematurity limits the specificity of total NGAL measurement as a marker of AKI.


Assuntos
Injúria Renal Aguda , Proteínas de Fase Aguda , Lipocalinas , Proteínas Proto-Oncogênicas , Injúria Renal Aguda/sangue , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/fisiopatologia , Proteínas de Fase Aguda/urina , Índice de Apgar , Biomarcadores/sangue , Biomarcadores/urina , Creatinina/sangue , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Recém-Nascido Prematuro/sangue , Testes de Função Renal/métodos , Lipocalina-2 , Lipocalinas/sangue , Lipocalinas/urina , Masculino , Proteínas Proto-Oncogênicas/sangue , Proteínas Proto-Oncogênicas/urina , Análise de Regressão , Reprodutibilidade dos Testes , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA